Our cGMP-led manufacturing facility has been approved by the Indian Drug Authorities, UK MHRA, Ukrainian Authorities, TGA Australia, Health Canada and Kazakhstan Authorities.

Facility Highlights
  • Designed to conform to EU and FDA cGMP regulations
  • Capacity of 2 billion units p.a. (Tablets – 1,800 million; Capsules – 200 million; Sachets – 15 million)
  • Four manufacturing modules: Three for high-volume products & one for low-volume products
  • A dedicated capsulation section having the facility of tablet filling in capsule, micro tablet filling, pellet filling and powder filling
  • Purified water distribution pipeline from RathGibson and a PLC-based distribution system
  • Conforming to Class 100,000 requirements, up-gradable to Class 10,000 as per requirements
  • Low RH up to 30% for areas like Granulation, Compression and Capsulation
  • Dedicated block for manufacturing hormonal products, with a built-up capacity of 100 million p.a.

Technical packaging is available for each product and CTD format dossiers are ready for key products. We are interested in developing new products exclusively for customer-specific needs and producing them on commercial scale.